Abridge said Thursday, in a hiring-blog post ostensibly about a chief revenue officer opening, that its annualized recurring revenue crossed $500 million during the second quarter of 2026, up from the $350 million figure it confirmed on the record in April. The blog is a soft touch for the Series F process the company is currently running, per two investors who have seen the deck. The number itself is not the interesting part. What it means for the category is.
Ambient clinical scribing, the product pattern of putting a microphone in the exam room, transcribing the doctor-patient conversation, and structuring it into an EHR note in real time, is now the largest applied-AI category by revenue in US healthcare. Larger than clinical decision support. Larger than imaging AI. Larger than revenue-cycle AI. It got there in roughly thirty months from research demo to category leader crossing half a billion in ARR. Nuance and Microsoft’s DAX product still owns the largest legacy installed base by contract volume. Abridge is winning the newer deals. Suki, Nabla, and Ambience are running smaller books at faster growth rates. Everyone in the category is at or beyond operating breakeven, which is not a sentence anyone can write about most applied-AI categories at this scale.
The reason ambient scribing worked is worth writing down, because the rest of applied AI keeps trying to imitate it and mostly missing the point. It saves physicians roughly ninety minutes per day of after-hours documentation work. Health systems pay for it out of the operating budget rather than the IT capital budget, which cuts twelve months off the procurement cycle. The ROI shows up in visit throughput and physician-satisfaction scores within a single quarter, both of which are metrics hospital COOs already have dashboards for. It is one of the very few AI deployments in any vertical where the buyer, the end user, and the value case are all the same person, and where the sales motion does not require the vendor to convince the buyer that AI is trustworthy in general before selling them a specific product.
Healthcare was supposed to be the vertical where AI deployment would be hardest. The regulatory environment, the malpractice exposure, the entrenched EHR vendors, the resistance from clinical staff. All of that turned out to be real, and ambient scribing routed around all of it by staying inside the existing physician-EHR workflow rather than trying to change it. The scribe does not diagnose. It does not prescribe. It does not sit anywhere in the decision path that would trigger FDA review as a clinical device. It transcribes and structures, which is a documentation task with a documentation-tool regulatory posture.
The read for anyone building applied AI in adjacent verticals is that the ambient-transcription pattern is the one to steal, and the verticals where it is going to be stolen fastest are legal, accounting, financial advisory, and insurance claims. The read for anyone building an “AI-first EHR” or an “AI-first legal-work platform” is that the ambient pattern just ate another year of the greenfield window you were counting on, because ambient scribing installed at 187 health systems means 187 health systems that just tested AI in a bounded workflow and are now open to expanding scope rather than replatforming.
The uncomfortable read for the model labs is that Abridge and its category peers are effectively a specialized-application layer sitting on top of frontier models, and the category economics work because the application layer captures the margin. The models are inputs. The workflow, the EHR integration, the physician trust, the sales team, and the deployment-services muscle are the product. That is the shape of durable applied AI. Every serious enterprise-AI conversation for the next two years starts from this table.